SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation has introduced the new BioMark system based on unique nanofluidic chips for real-time PCR. Accordingly, the Company has invited scientists engaged in quantitative gene analysis to a web-based event on Thursday, May 10, at 3:00 PM, London time. The event includes a short presentation by Fluidigm director of R&D, Dr. Marc Unger, and panelist Dr. Rick Gerren of Source MDx, who is a BioMark system user. Those interested are asked to enroll at the following link: https://fluidigm.webex.com/fluidigm/onstage/g.php?t=a&d=807956919.
